MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Low Grade Glioma · High Grade Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Ashley Plant-Fox, MD

    Principal Investigator

    Ann & Robert H Lurie Children's Hospital of Chicago